Metrics Expands Analytical Lab Capabilities with Additional UPLC Equipment
News Aug 19, 2015
Metrics Contract Services (Metrics) is expanding its analytical lab capabilities by adding two new UPLC systems.
Metrics has acquired two new Waters ACQUITY Ultra Performance Liquid Chromatography™ H-class (UPLC) systems. These additional UPLC systems will help the company’s chemists produce better resolution liquid-chromatography separations in shorter analysis times, thus improving characterization of complex samples.
“Our clients have been requesting our help with exactly these types of analytical projects, so it’s exciting to expand our capabilities in support of our customers’ programs,” said Jennifer Alligood, associate director of analytical services.
This equipment acquisition is the latest in a series of investments Metrics has been making in its physical facilities and equipment. Most recently, the company added a Thermo Scientific™ iCAP™ Q ICP-MS mass spectrometer and a Milestone UltraWAVE Single Reaction Chamber digestion vessel.
“Metrics’ ongoing investment in leading-edge laboratory technologies reflects our commitment to providing clients with scientific excellence - in terms of providing quality data and fast turnaround times, as well as thoughtful interpretation of what those results mean for them,” Alligood added.
Metrics has long appreciated the importance of analytical support within the context of pharmaceutical development and manufacturing. Today, Metrics has more than 90 analytical chemists on staff - which represents an industry-leading four analytical chemists for every one of the company’s formulation experts.
Metrics analytical chemists work within a current Good Manufacturing Practices-complaint facility on a wide range of oral dosage forms, including potent, cytotoxic, light-sensitive, temperature-sensitive, DEA-regulated, and other challenging molecules.
Nanotechnology Detects Molecular Biomarker for OsteoarthritisNews
For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.READ MORE
Blood Donors' Leftover Immune Cells Reveal Secrets of Antibody AffinityNews
During some kinds of blood donations, such as platelet donation, you get most of the blood back. Researchers have been able to use leftover blood donor cells to gain crucial insights into how natural killer cells circulating in the human body differ from those typically studied in the lab.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Clinical And Medical Microbiology
Sep 10 - Sep 11, 2018